Clinical Trials in San Francisco

Showing 8821-8840 of 9,883 trials

Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis

NCT00800982

This is a single-center, open-label, pilot study. A total of 30 subjects (15 in each study arm) will be enrolled in this 6 month study to evaluate whether the addition of narrow band UVB (NB-UVB) phototherapy can enhance the efficacy of etanercept's maintenance dose, 50 mg once a week, in obese psoriasis patients.

Psoriasis

University of California, San Francisco30 participantsStarted Oct 2008

San Francisco, California, United States

COMPLETEDPhase 3< 1 mile

Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero®.

NCT00876265

This was a study to find out how an investigational product, Belotero, compares to a second product in people with facial wrinkles, such as nasolabial folds. Nasolabial folds are wrinkles on the face that go from the outside of the nostrils to the edges of the mouth. Additionally, this study determined Belotero is safe and tolerable and corrects facial wrinkles, such as nasolabial folds.

Facial Wrinkles

Merz North America, Inc.118 participantsStarted Dec 2006

Birmingham, Alabama, United States • Los Angeles, California, United States • San Francisco, California, United States +3 more locations

Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis

Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero®.

Find Trials by Condition in San Francisco

Modified Directly Observed Therapy for Improving Antiretroviral Therapy Adherence in People With HIV

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

THE IMPROVE TRIAL: Improving Pain Management and Outcomes With Various Strategies of Patient-Controlled Analgesia (PCA)

A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents

Initial Validation of PROMIS Physical Function/Disability Scales in Rheumatoid Arthritis (RA)

Treatment of Moderate to Severe Facial Acne Vulgaris

A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer

Indacaterol 75 μg Compared to Placebo, Assessing Time to Patient's Perception of Onset of Effect in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors

Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer

Safety Study of Post Tonsillectomy Ibuprofen Use in Adults

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer

Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors

Pilot Study of Minocycline in Huntington's Disease